Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1

NCT00089570 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatorenal Syndrome

Interventions

DRUG: terlipressin
DRUG: Placebo

Sponsor

Mallinckrodt